# Jazz Pharmaceuticals plc (JAZZ) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Jazz Pharmaceuticals plc's 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/JAZZ/mda/fy2025/): filed 2026-02-24; accession 0001232524-26-000013 (https://www.sec.gov/Archives/edgar/data/1232524/000123252426000013/jazz-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/JAZZ/mda/fy2024/): filed 2025-02-26; accession 0001232524-25-000011 (https://www.sec.gov/Archives/edgar/data/1232524/000123252425000011/jazz-20241231.htm)
- [FY 2023 MD&A](/company/JAZZ/mda/fy2023/): filed 2024-02-28; accession 0001232524-24-000015 (https://www.sec.gov/Archives/edgar/data/1232524/000123252424000015/jazz-20231231.htm)
- [FY 2022 MD&A](/company/JAZZ/mda/fy2022/): filed 2023-03-01; accession 0001232524-23-000015 (https://www.sec.gov/Archives/edgar/data/1232524/000123252423000015/jazz-20221231.htm)
- [FY 2021 MD&A](/company/JAZZ/mda/fy2021/): filed 2022-03-01; accession 0001232524-22-000012 (https://www.sec.gov/Archives/edgar/data/1232524/000123252422000012/jazz-20211231.htm)

Back to /company/JAZZ/